143 related articles for article (PubMed ID: 8388260)
1. Cell function and viability in glucose polymer peritoneal dialysis fluids.
Liberek T; Topley N; Mistry CD; Coles GA; Morgan T; Quirk RA; Williams JD
Perit Dial Int; 1993; 13(2):104-11. PubMed ID: 8388260
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH.
Liberek T; Topley N; Jörres A; Petersen MM; Coles GA; Gahl GM; Williams JD
Nephron; 1993; 65(2):260-5. PubMed ID: 8247190
[TBL] [Abstract][Full Text] [Related]
3. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro.
Cendoroglo M; Sundaram S; Jaber BL; Pereira BJ
Am J Kidney Dis; 1998 Feb; 31(2):273-82. PubMed ID: 9469498
[TBL] [Abstract][Full Text] [Related]
4. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.
Sundaram S; Cendoroglo M; Cooker LA; Jaber BL; Faict D; Holmes CJ; Pereira BJ
Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration.
Liberek T; Topley N; Jörres A; Coles GA; Gahl GM; Williams JD
J Am Soc Nephrol; 1993 Feb; 3(8):1508-15. PubMed ID: 8387831
[TBL] [Abstract][Full Text] [Related]
6. In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid.
Topley N; Mackenzie R; Petersen MM; Beavis MJ; Williams D; Thomas N; Faict D; Peluso F; Coles GA; Davies M
Nephrol Dial Transplant; 1991; 6(8):574-81. PubMed ID: 1659676
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.
Topley N; Kaur D; Petersen MM; Jörres A; Williams JD; Faict D; Holmes CJ
J Am Soc Nephrol; 1996 Feb; 7(2):218-24. PubMed ID: 8785390
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of glucose polymer-containing peritoneal dialysis fluids on phagocytic activity.
Thomas S; Schenk U; Fischer FP; Mettang T; Passlick-Deetjen J; Kuhlmann U
Am J Kidney Dis; 1997 Feb; 29(2):246-53. PubMed ID: 9016897
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function.
Topley N; Kaur D; Petersen MM; Jörres A; Passlick-Deetjen J; Coles GA; Williams JD
Kidney Int; 1996 May; 49(5):1447-56. PubMed ID: 8731113
[TBL] [Abstract][Full Text] [Related]
10. In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions.
Jörres A; Gahl GM; Topley N; Neubauer A; Ludat K; Müller C; Passlick-Deetjen J
Nephrol Dial Transplant; 1994; 9(7):785-90. PubMed ID: 7970120
[TBL] [Abstract][Full Text] [Related]
11. In vitro simulation of the effect of peritoneal dialysis solution on mesothelial cells.
Breborowicz A; Rodela H; Karoń J; Martis L; Oreopoulos DG
Am J Kidney Dis; 1997 Mar; 29(3):404-9. PubMed ID: 9041217
[TBL] [Abstract][Full Text] [Related]
12. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid.
de Fijter CW; Verbrugh HA; Oe LP; Heezius E; Donker AJ; Verhoef J; Gokal R
Am J Kidney Dis; 1993 Apr; 21(4):411-8. PubMed ID: 8465822
[TBL] [Abstract][Full Text] [Related]
14. Newly Developed Neutralized pH Icodextrin Dialysis Fluid: Nonclinical Evaluation.
Yamaguchi N; Miyamoto K; Murata T; Ishikawa E; Horiuchi T
Artif Organs; 2016 Aug; 40(8):E158-66. PubMed ID: 27530675
[TBL] [Abstract][Full Text] [Related]
15. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
Plum J; Schoenicke G; Grabensee B
Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
[TBL] [Abstract][Full Text] [Related]
16. Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation.
Ha H; Yu MR; Choi HN; Cha MK; Kang HS; Kim MH; Lee HB
Perit Dial Int; 2000; 20 Suppl 5():S10-8. PubMed ID: 11229606
[TBL] [Abstract][Full Text] [Related]
17. Glucose-based dialysis fluids inhibit innate defense against Staphylococcus aureus.
Kumar PS; Mauriello CT; Hair PS; Rister NS; Lawrence C; Raafat RH; Cunnion KM
Mol Immunol; 2015 Oct; 67(2 Pt B):575-83. PubMed ID: 26256795
[TBL] [Abstract][Full Text] [Related]
18. The effect of peritoneal dialysis fluid on the release of IL-1 beta and TNF alpha by macrophages/monocytes.
Douvdevani A; Rapoport J; Konforti A; Zlotnik M; Chaimovitz C
Perit Dial Int; 1993; 13(2):112-7. PubMed ID: 8494931
[TBL] [Abstract][Full Text] [Related]
19. Comparison of icodextrin- and glucose-based peritoneal dialysis fluids in their acute and chronic effects on human peritoneal mesothelial cells.
Bender TO; Witowski J; Ksiazek K; Jörres A
Int J Artif Organs; 2007 Dec; 30(12):1075-82. PubMed ID: 18203069
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro.
van Bronswijk H; Verbrugh HA; Bos HJ; Heezius EC; Oe PL; van der Meulen J; Verhoef J
Perit Dial Int; 1989; 9(3):197-202. PubMed ID: 2488365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
